Search results
From Proteopedia
You searched for Pharmacokinetic
There is no page with the exact title "Pharmacokinetic". The search results for "Pharmacokinetic" are displayed below. You can create a page titled Pharmacokinetic (by clicking on the red link).
For more information about searching Proteopedia, see Help.
Showing below up to 20 results starting with #1.
View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)
Article title matches
- Category:Pharmacokinetic (46 bytes)
1: List of pages with the keyword Pharmacokinetic - Category:Pharmacokinetic property (55 bytes)
1: List of pages with the keyword Pharmacokinetic property - Category:Pharmacokinetic sensor (53 bytes)
1: List of pages with the keyword Pharmacokinetic sensor
Page text matches
- 9bik (4,099 bytes)
14: ...in vitro safety profile, and good projected human pharmacokinetics. - 2j94 (5,654 bytes)
26: ...rved within this series of potent fXa inhibitors. Pharmacokinetic profiles in rat and dog, together with selectivit... - 2j95 (5,600 bytes)
26: ...rved within this series of potent fXa inhibitors. Pharmacokinetic profiles in rat and dog, together with selectivit... - 1h1b (6,554 bytes)
26: ...ibitors, with a prolonged pharmacodynamic action. Pharmacokinetically, these compounds are comparable with 1 while ... - 2jc1 (9,028 bytes)
24: ...ubmicromolar potency in the HCV replicon and good pharmacokinetic properties. - 2jc0 (9,030 bytes)
24: ...ubmicromolar potency in the HCV replicon and good pharmacokinetic properties. - 2uzw (7,305 bytes)
24: ...improved cardiovascular safety profile. The SARs, pharmacokinetic profile, and CV safety of selected Akt inhibitors... - 2uzt (7,322 bytes)
24: ...improved cardiovascular safety profile. The SARs, pharmacokinetic profile, and CV safety of selected Akt inhibitors... - 2uzu (7,340 bytes)
24: ...improved cardiovascular safety profile. The SARs, pharmacokinetic profile, and CV safety of selected Akt inhibitors... - 2uzv (5,295 bytes)
24: ...improved cardiovascular safety profile. The SARs, pharmacokinetic profile, and CV safety of selected Akt inhibitors... - 2j14 (4,553 bytes)
24: ...nvestigated and optimized for a favorable in vivo pharmacokinetic profile. Isoxazole LCI765 (17d) was found to be a... - 2j50 (5,903 bytes)
24: ...cancer cell lines, favorable chemico-physical and pharmacokinetic properties, and high efficacy in in vivo tumor mo... - 1w5w (11,987 bytes)
24: ...e development of potent inhibitors with different pharmacokinetic profiles towards resistant protease mutants. - 1w5y (11,987 bytes)
24: ...e development of potent inhibitors with different pharmacokinetic profiles towards resistant protease mutants. - 1w5x (11,987 bytes)
24: ...e development of potent inhibitors with different pharmacokinetic profiles towards resistant protease mutants. - 1w5v (11,924 bytes)
24: ...e development of potent inhibitors with different pharmacokinetic profiles towards resistant protease mutants. - 1uom (6,986 bytes)
24: ...fect of N-phenyl substituents on the activity and pharmacokinetic properties of tetrahydroisoquinoline analogues wa... - 2bm2 (5,402 bytes)
24: ...change of the benzamidine to optimize potency and pharmacokinetic properties gave selective, potent and orally bioa... - 2bhj (4,257 bytes)
24: ...wo compounds (16 and 30) demonstrate a reasonable pharmacokinetic profile in rodents. The synthesis, SAR, and biolo... - 4j3j (5,239 bytes)
14: ...e performed on this series, revealing undesirable pharmacokinetic profiles for the triazole compounds. To overcome ...
View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)
